|

Product Overview ..........................................................................................................
©
Web-based Software for
Investigational Drug Inventory Management
Investigational Drug Environmental Accountability (IDEA©) is a comprehensive Web-based program for all aspects of investigational drug inventory management and dispensing. It incorporates elements for inventory control and audit performance required by clinical trials sponsoring organizations, including the National Cancer Institute.
Whereas most drug inventory systems only provide information as to inventory on hand, IDEA© allows clinical research sites the ability to have "look ahead" capability in order to plan for future inventory needs and be able to meet those needs in a variety of ways. This extraordinary feature distinguishes IDEA© from any other drug inventory system on the market today.
IDEA© may be utilized as a stand-alone pharmacy system or incorporated as a module into CREDIT©, the clinical trials administration and patient scheduling software developed by DDOTS.
The development of IDEA© Web-based software was supported by Grant No. 1U43CA78105-01 from the National Cancer Institute, Small Business Innovations Research program. Its contents are solely the responsibility of DDOTS, Inc. and do not necessarily represent the official views of the National Cancer Institute.

The capabilities of IDEA© are highlighted as follows:
PHARMACY
DRUG ACCOUNTABILITY RECORDS (DAR)
 |
Automatically Recorded Seamlessly records user activities by automatically updating DARs via Pharmacist activities. |
 |
Viewable per Patient, Protocol, Agent Allows for simple navigation between various views of a compound DAR |
 |
Pharmacy Specific Tracks DARs for an unlimited number of pharmacies (Inpatient, Outpatient...etc.) |
 |
Memo Fields Provides an easy way to attach a narrative to each and every DAR entry. |
 |
Security and Notation Entries Simplifies adding a narrative to any DAR without needing to create an "Event Entry". The user of author owns all notations and memos. Other users may view, but not edit these entries. |
PROTOCOLS
 |
Base Data Captures the National identifier, Sponsor, Disease Site, Title and Local Coordinator. |
 |
Arm Identifiers Tag any protocol arm with A-Z, 1-26. |
 |
Schema Definitions Establishes a segment of treatment time (Weeks/Days, Months/Years) capable of unlimited duration. Supports multiple overlay segments for each arm. |
 |
Treatment Agents Allows for the selection of the agent by generic or formal name. Determines if the agent can be "date adjusted (cascaded)" on patient schedules. Assigns the agent as provided or not, patient specific or not. |
 |
Establish Treatment Cycles Simplifies establishment of treatment cycles through check off of appropriate Day, Week, Month, or Year the treatment is to be given. For example, a treatment cycle for an agent to be given on Day 1, every 35 days x 5 cycles only requires the user to place 5 checks in boxes on the displayed page. |
PATIENTS
 |
Demographics User enters a patient name and zip code. IDEA(c) selects the City, State and telephone area code. Provides capability to load in a digital photograph of the patient. All standard demographics are allowed including a notepad area. |
 |
Protocol Assignment User selects a protocol and arm for a patient and enters the date treatment begins. IDEA© creates the entire schedule from the master protocol schema. |
 |
Schedule Tracking As treatments occur in the Pharmacy module, the event is automatically logged in the patient schedule. If treatment delay is required, simply select the starting point of the delay and re-assign the new date. IDEA© automatically "Cascades" the patient schedule to accommodate the delay. |
..........................................................................................................
Who should use IDEA©?
Why is IDEA© so important?
 |
Inaccurate investigational agent tracking does exist. This is greatly problematic for the National Institutes of Health (NIH,) including the National Cancer Institute (NCI,) and other organizations conducting clinical research. Consequences of improper tracking include potential invalid research results, cessation of funding by sponsoring agencies, and potential patient safety issues. |
 |
It is critical to have a solution for poor accountability. The implications for an inefficient agent tracking system are costly. Agents that are left to expire and returned to the sponsor are of major concern. Exhausting the supply of an agent that is required for current treatment often results in the substitution of a commercial agent. This can invalidate research results and is one of the core issues during an audit. |
 |
IDEA© has been demonstrated to be a vital tool for the busy pharmacy involved in clinical trials. Because IDEA© is "Intranet Browser" based, it can be used on any platform that supports Internet Explorer or Netscape. |
..........................................................................................................
Specifications: Server Software Specifications (Minimum):
 |
Windows 2000/2003 Server |
 |
SQL Server 2000 |
 |
WebEditPro 4.0 + |
 |
Internet Explorer 6.x |
 |
ColdFusionMX 7.x | Server Hardware Specifications (Minimum):
 |
1ghz Processor |
 |
1gb RAM |
 |
5gb Drive Space | Workstation Specifications (Minimum):
 |
If Windows based, Windows 98, Windows 2000, Windows XP |
 |
450mhz Processor |
 |
64mb RAM (preferred 128mb) |
 |
Internet Explorer 6.x |
|